001680.KS
Daesang Corporation [001680.KS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
001680.KS Stock Summary
Top 10 Correlated ETFs
001680.KS
Top 10 Correlated Stocks
001680.KS
In the News
001680.KS Financial details
Company Rating
Buy
Market Cap
706.82B
Income
84.41B
Revenue
4126.42B
Book val./share
-
Cash/share
-
Dividend
800
Dividend %
4.04%
Employees
4.92K
Optionable
No
Shortable
Yes
Earnings
07 Feb 2024
P/E
8.45
Forward P/E
-
PEG
-2.05
P/S
0.17
P/B
0.53
P/C
-
P/FCF
44.3
Quick Ratio
-
Current Ratio
1.86
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
2.35K
EPS next Y
-
EPS next Q
-
EPS this Y
-42.36%
EPS next Y
-
EPS next 5Y
-12.86%
EPS last 5Y
5.07%
Revenue last 5Y
6.67%
Revenue Q/Q
11.94%
EPS Q/Q
-4.86%
-
-
-
-
SMA20
4.33%
SMA50
13.57%
SMA100
17.97%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
6%
ROC
0.06%
Gross Margin
25%
Oper. Margin
3%
Profit Margin
2%
Payout
-
Shs Outstand
35.8M
Shs Float
22.08M
-
-
-
-
Target Price
-
52W Range
16090.0-23050.0
52W High
-14.1%
52W Low
+23.06%
RSI
47
Rel Volume
3.78
Avg Volume
93.82K
Volume
354.45K
Perf Week
-2.94%
Perf Month
3.29%
Perf Quarter
5.71%
Perf Half Y
4.05%
-
-
-
-
Beta
0.489
-
-
Volatility
360.41%, 503.13%
Prev Close
-4.81%
Price
19800
Change
-6.16%
001680.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 82.08K | 82.28K | 86.43K | 96.32K | 113.37K | |
| Net income per share | 1.8K | 2.98K | 3.47K | 4K | 2.31K | |
| Operating cash flow per share | 3.37K | 4.64K | 3.36K | 1.63K | -2.52K | |
| Free cash flow per share | -761.57 | 1.48K | 274.62 | -2.95K | -7.51K | |
| Cash per share | 7.7K | 11.56K | 14.91K | 16.87K | 16.26K | |
| Book value per share | 25.4K | 27.89K | 30.08K | 34.06K | 36.18K | |
| Tangible book value per share | 22.13K | 24.88K | 27.53K | 31.52K | 33.41K | |
| Share holders equity per share | 25.4K | 27.89K | 30.08K | 34.06K | 36.18K | |
| Interest debt per share | 22.73K | 23.87K | 24.75K | 28.36K | 38.15K | |
| Market cap | 886.16B | 835.73B | 938.35B | 839.38B | 772.69B | |
| Enterprise value | 1514.88B | 1445.18B | 1302.65B | 1257.33B | 1557.28B | |
| P/E ratio | 13.66 | 7.8 | 7.5 | 5.82 | 9.3 | |
| Price to sales ratio | 0.3 | 0.28 | 0.3 | 0.24 | 0.19 | |
| POCF ratio | 7.29 | 5 | 7.75 | 14.31 | -8.5 | |
| PFCF ratio | -32.3 | 15.71 | 94.86 | -7.9 | -2.86 | |
| P/B Ratio | 0.97 | 0.83 | 0.87 | 0.68 | 0.59 | |
| PTB ratio | 0.97 | 0.83 | 0.87 | 0.68 | 0.59 | |
| EV to sales | 0.51 | 0.49 | 0.42 | 0.36 | 0.38 | |
| Enterprise value over EBITDA | 6.43 | 5.6 | 3.99 | 4.93 | 5.71 | |
| EV to operating cash flow | 12.46 | 8.64 | 10.76 | 21.43 | -17.13 | |
| EV to free cash flow | -55.22 | 27.17 | 131.69 | -11.83 | -5.76 | |
| Earnings yield | 0.07 | 0.13 | 0.13 | 0.17 | 0.11 | |
| Free cash flow yield | -0.03 | 0.06 | 0.01 | -0.13 | -0.35 | |
| Debt to equity | 0.87 | 0.83 | 0.8 | 0.82 | 1.03 | |
| Debt to assets | 0.36 | 0.35 | 0.34 | 0.35 | 0.42 | |
| Net debt to EBITDA | 2.67 | 2.36 | 1.11 | 1.64 | 2.88 | |
| Current ratio | 1.23 | 1.36 | 1.67 | 1.6 | 1.73 | |
| Interest coverage | 5.1 | 5.33 | 8.38 | 8.73 | 4.57 | |
| Income quality | 1.86 | 1.54 | 0.95 | 0.4 | -1.11 | |
| Dividend Yield | 0.02 | 0.02 | 0.02 | 0.03 | 0.04 | |
| Payout ratio | 0.28 | 0.18 | 0.17 | 0.18 | 0.35 | |
| Sales general and administrative to revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Intangibles to total assets | 0.06 | 0.05 | 0.04 | 0.04 | 0.04 | |
| Capex to operating cash flow | -1.23 | -0.68 | -0.92 | -2.81 | 1.97 | |
| Capex to revenue | -0.05 | -0.04 | -0.04 | -0.05 | -0.04 | |
| Capex to depreciation | -1.81 | -1.16 | -1.06 | -1.5 | -1.41 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 32.08K | 43.22K | 48.48K | 55.37K | 43.33K | |
| ROIC | 0.04 | 0.05 | 0.06 | 0.05 | 0.04 | |
| Return on tangible assets | 0.03 | 0.05 | 0.05 | 0.05 | 0.03 | |
| Graham Net | -16.73K | -15.23K | -11.38K | -12.71K | -16.85K | |
| Working capital | 166.46B | 282.7B | 520.7B | 569.63B | 723.77B | |
| Tangible asset value | 797.02B | 896.16B | 991.56B | 1135.45B | 1203.42B | |
| Net current asset value | -365.35B | -297.1B | -124.57B | -99.88B | -146.57B | |
| Invested capital | 0.87 | 0.83 | 0.8 | 0.82 | 1.03 | |
| Average receivables | 320.65B | 311.04B | 353.1B | 395.1B | 414.52B | |
| Average payables | 150.61B | 127.65B | 131.74B | 164.12B | 188.28B | |
| Average inventory | 319.94B | 333.4B | 360.08B | 445.22B | 610.79B | |
| Days sales outstanding | 37.71 | 38.99 | 45.67 | 42.14 | 38.29 | |
| Days payables outstanding | 20.09 | 22.25 | 20.75 | 28.14 | 20.76 | |
| Days of inventory on hand | 53.63 | 56.96 | 60.46 | 72.68 | 82.82 | |
| Receivables turnover | 9.68 | 9.36 | 7.99 | 8.66 | 9.53 | |
| Payables turnover | 18.17 | 16.41 | 17.59 | 12.97 | 17.58 | |
| Inventory turnover | 6.81 | 6.41 | 6.04 | 5.02 | 4.41 | |
| ROE | 0.07 | 0.11 | 0.12 | 0.12 | 0.06 | |
| Capex per share | -4.14K | -3.17K | -3.09K | -4.58K | -4.98K |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 30.64K | 28.03K | 27.45K | 27.88K | 0 | |
| Net income per share | 179.37 | 527.2 | 365 | 744 | 0 | |
| Operating cash flow per share | 1.38K | -986.82 | 3.03K | 3.19K | 0 | |
| Free cash flow per share | -1.35K | -1.88K | 2.87K | 754.42 | 0 | |
| Cash per share | 18.78K | 16.27K | 20.46K | 19.75K | 0 | |
| Book value per share | 37.57K | 36.19K | 36.21K | 37.02K | 0 | |
| Tangible book value per share | 34.31K | 33.42K | 33.44K | 33.44K | 0 | |
| Share holders equity per share | 37.57K | 36.19K | 36.21K | 37.02K | 0 | |
| Interest debt per share | 40.68K | 37.63K | 38.94K | 39.26K | 0 | |
| Market cap | 746.66B | 772.4B | 706.94B | 618.21B | 0 | |
| Enterprise value | 1536.59B | 1556.99B | 1383.24B | 1330.05B | 0 | |
| P/E ratio | 30.04 | 10.17 | 13.43 | 5.77 | 0 | |
| Price to sales ratio | 0.7 | 0.77 | 0.71 | 0.62 | 0 | |
| POCF ratio | 15.62 | -21.74 | 6.47 | 5.38 | 0 | |
| PFCF ratio | -16 | -11.39 | 6.84 | 22.76 | 0 | |
| P/B Ratio | 0.57 | 0.59 | 0.54 | 0.46 | 0 | |
| PTB ratio | 0.57 | 0.59 | 0.54 | 0.46 | 0 | |
| EV to sales | 1.45 | 1.54 | 1.4 | 1.33 | 0 | |
| Enterprise value over EBITDA | 28.84 | 24.23 | 21.37 | 5.22 | 0 | |
| EV to operating cash flow | 32.15 | -43.82 | 12.65 | 11.59 | 0 | |
| EV to free cash flow | -32.92 | -22.96 | 13.39 | 48.97 | 0 | |
| Earnings yield | 0.01 | 0.02 | 0.02 | 0.04 | 0 | |
| Free cash flow yield | -0.06 | -0.09 | 0.15 | 0.04 | 0 | |
| Debt to equity | 1.08 | 1.03 | 1.07 | 1.05 | 0 | |
| Debt to assets | 0.41 | 0.42 | 0.42 | 0.42 | 0 | |
| Net debt to EBITDA | 14.83 | 12.21 | 10.45 | 2.79 | 0 | |
| Current ratio | 1.61 | 1.73 | 1.86 | 1.89 | 1.86 | |
| Interest coverage | 2.26 | 2.69 | 1.91 | 2.59 | 0 | |
| Income quality | 9.02 | -1.84 | 8.09 | 4.28 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.02 | 0.02 | 0.02 | 0.22 | 0.22 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
| Intangibles to total assets | 0.04 | 0.04 | 0.04 | 0.05 | 0 | |
| Capex to operating cash flow | -1.98 | 0.91 | -0.06 | -0.76 | 0 | |
| Capex to revenue | -0.09 | -0.03 | -0.01 | -0.09 | 0 | |
| Capex to depreciation | -2.83 | -0.96 | -0.19 | -2.54 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 12.31K | 20.72K | 17.25K | 24.9K | 0 | |
| ROIC | 0 | 0.01 | 0.01 | 0.01 | 0.03 | |
| Return on tangible assets | 0 | 0.01 | 0 | 0.01 | 0.01 | |
| Graham Net | -20.19K | -16.86K | -16.17K | -17.01K | 0 | |
| Working capital | 696.74B | 723.77B | 827.1B | 833.89B | 867.81B | |
| Tangible asset value | 1188.65B | 1203.42B | 1205.58B | 1204.14B | 1380.69B | |
| Net current asset value | -217.16B | -146.57B | -159.36B | -185.1B | -174.02B | |
| Invested capital | 1.08 | 1.03 | 1.07 | 1.05 | 0 | |
| Average receivables | 462.71B | 446.78B | 421.24B | 416.87B | 209.82B | |
| Average payables | 229.24B | 211.78B | 187.57B | 193.78B | 94.76B | |
| Average inventory | 687.24B | 719.08B | 673.15B | 642.36B | 322.47B | |
| Days sales outstanding | 39.43 | 38.2 | 37.66 | 37.63 | 0 | |
| Days payables outstanding | 27.46 | 20.41 | 23.54 | 22.78 | 0 | |
| Days of inventory on hand | 81.51 | 81.44 | 76.06 | 77.52 | 0 | |
| Receivables turnover | 2.28 | 2.36 | 2.39 | 2.39 | 0 | |
| Payables turnover | 3.28 | 4.41 | 3.82 | 3.95 | 0 | |
| Inventory turnover | 1.1 | 1.11 | 1.18 | 1.16 | 0 | |
| ROE | 0 | 0.01 | 0.01 | 0.02 | 0.02 | |
| Capex per share | -2.73K | -895.99 | -166.87 | -2.43K | 0 |
001680.KS Frequently Asked Questions
What is Daesang Corporation stock symbol ?
Daesang Corporation is a KR stock and trading under the symbol 001680.KS
What is Daesang Corporation stock quote today ?
Daesang Corporation stock price is $19800 today.
Is Daesang Corporation stock public?
Yes, Daesang Corporation is a publicly traded company.
Company Profile
- Volume Average 93.82K
- Market Capitalization 706.82B
- Employee 4.92K
- CEO Mr. Jung-Bae Lim
- Headquarters Seoul,KR
- IPO Date 2000-01-04
-
Website
https://www.daesang.com 
Daesang Corporation, together with its subsidiaries, produces and sells various food products in South Korea and internationally. The company offers general food products, including bean pastes and seasonings; agro-fishery foods, such as vinegar and fish sauce; and fresh food products comprising Kimchi and tofu, western food, deli, frozen food, etc. It also provides food ingredients, such as starch for the use in food, paper, textile, and construction materials; and sweeteners for the use in alcohol drinks, confectionery, baking, and beverage industrial areas. In addition, the company offers bio ingredients, including flavor enhancers, amino acids, and microalgae based products for the use in food, dietary supplements, functional foods, animal nutrition, pet food, and pharmaceutical industries. Further, it exports various bio ingredient products to approximately 80 countries under the Miwon brand. Additionally, the company engages in the food distribution business. The company was founded in 1956 and is headquartered in Seoul, South Korea.
